Researcher.Life Logo

International Journal of Pharmaceutics: X : Impact Factor & More

eISSN: 2590-1567
JournalOpen Access

Key Metrics

Impact Factor
< 5
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Pharmaceutics: X

International Journal of Pharmaceutics: X Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Elsevier
Language English
Frequency Continuous publication
Article Processing ChargesUSD 1950
Publication Time17
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2019
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in International Journal of Pharmaceutics: X ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Pharmaceutics: X

Engineered M2 macrophage-derived vesicles deliver DNase I for cfDNA clearance and multi-organ protection in sepsis.
  • 1 Jun 2026
  • International journal of pharmaceutics: X
Oral milk-derived exosomes loaded with tafatinib for anti-inflammatory therapy
  • 1 Jun 2026
  • International Journal of Pharmaceutics: X
Placenta-oriented self-assembled Aspirin-RGDV nanoconjugates attenuate preeclampsia through restoration of angiogenic balance.
  • 1 Jun 2026
  • International journal of pharmaceutics: X
Can therapeutic potency of a cancer nanomedicine be predicted by pain-related behavioral test in subcutaneous tumor model?
  • 1 Jun 2026
  • International journal of pharmaceutics: X
Hesperidin-loaded Eudragit S100 nanoparticles alleviate ulcerative colitis by repairing intestinal barrier and modulating gut microbiota
  • 1 Jun 2026
  • International Journal of Pharmaceutics: X
Enhanced brain delivery of oleanolic acid by GSH-PEGylated liposomes and its amelioration of scopolamine-induced cognitive dysfunction via multi-target regulation.
  • 1 Jun 2026
  • International journal of pharmaceutics: X
Engineered M2 macrophage-derived vesicles deliver DNase I for cfDNA clearance and multi-organ protection in sepsis.
  • 1 Jun 2026
  • International journal of pharmaceutics: X
Oral milk-derived exosomes loaded with tafatinib for anti-inflammatory therapy
  • 1 Jun 2026
  • International Journal of Pharmaceutics: X
Placenta-oriented self-assembled Aspirin-RGDV nanoconjugates attenuate preeclampsia through restoration of angiogenic balance.
  • 1 Jun 2026
  • International journal of pharmaceutics: X
Can therapeutic potency of a cancer nanomedicine be predicted by pain-related behavioral test in subcutaneous tumor model?
  • 1 Jun 2026
  • International journal of pharmaceutics: X
Hesperidin-loaded Eudragit S100 nanoparticles alleviate ulcerative colitis by repairing intestinal barrier and modulating gut microbiota
  • 1 Jun 2026
  • International Journal of Pharmaceutics: X
Enhanced brain delivery of oleanolic acid by GSH-PEGylated liposomes and its amelioration of scopolamine-induced cognitive dysfunction via multi-target regulation.
  • 1 Jun 2026
  • International journal of pharmaceutics: X

FAQs on International Journal of Pharmaceutics: X